Soterix Medical launches tDCS trial for cocaine addiction

Soterix Medical said yesterday that it won a Phase I NIH-SBIR contract from the National Institute of Health’s National Institute of Drug Abuse to launch a trial of its remote transcranial direct current stimulation platform intended to treat cocaine addiction.
The Phase I contract comes with a value of approximately $475,000 delivered over a period of eight months and supports the application to a Phase II award for a larger efficacy trial which will culminate in an FDA marketing tri